propylaminecarbonic acid benzyl ester 4-dimethylamino-2-[2-ethyl-3,4,10-trihydroxy-13-(8-methoxy-4,8-dimethyl-1,5-dioxa-spiro[2.5]°Ct-6-yloxy)-3,5,8,10,12,14-hexamethyl-15-oxo-1-oxa-6-aza-cyclopentadec-11-yloxy]-6-methyl-tetrahydro-pyran-3-yl estererythromycin A 9-(E)-oxime9-Deoxo-9a-aza-9a-homoerythromycin A
合成工艺路线路线简述
阿奇霉素 A置于palladium 10% On Activated Carbon,Potassium Tert-Butylate,氢气,Potassium Carbonate,戴斯-马丁氧化剂,Sodium Sulfate体系中,用 四氢呋喃,二氯甲烷,水,二甲基亚砜,异丙醇,丙酮 用作溶剂,-85.0~65.0 °C,250.0 Kpa 条件下,反应 4.5H,反应生成托拉菌素 A 参考文献:泰拉菌素中间体的盐 标题:泰拉菌素中间体的盐 摘要:本发明公开了一种制备泰拉菌素的中间体的盐,具体来说该盐为草酸盐,及其制备方法和在制备泰拉菌素的方法中的应用.
专利号:WO-2025056767-A1 优先权日:2023-09-15 标题 :Process for the preparation of enantiomerically enriched aliphatic amines 发明人:BOU HAMDAN FARHAN; GODINEAU EDOUARD; SMEJKAL TOMAS; DUMEUNIER RAPHAEL; BOUSSEMGHOUNE MOHAMED ABDELOUAHAB; BLUM MATHIAS 权利人:SYNGENTA CROP PROTECTION AG 摘要:The present invention relates to a process for the preparation of enantiomerically enriched cyclobutylamines of formula (I) from α-tertiary cyclobutanones and reacting said enantiomerically enriched cyclobutylamines to enantiomerically enriched cyclobutylamides. Such compounds are useful intermediates in the synthesis of microbiocidal thiazole compounds.
专利号:CN-119638694-A 优先权日:2018-11-16 标 题 :Improved synthesis of key intermediates for KRAS G12C inhibitor compounds
专利号:CN-114728960-B 优先权日:2019-11-14 标 题:Improved synthesis of KRAS G12C inhibitor compounds
专利号:CN-113015724-B 优先权日:2018-11-16 标题 :Improved synthesis of key intermediates for KRAS G12C inhibitor compounds
专利号:CN-119638693-A 优先权日:2018-11-16 标 题 :Improved synthesis of key intermediates for KRAS G12C inhibitor compounds
专利号:CN-104119413-B 优先权日:2014-07-29 标题:A kind of synthesis method of tulamycin residue marker
1: Abell KM, Theurer ME, Larson RL, White BJ, Apley M. A mixed treatment comparison meta-analysis of metaphylaxis treatments for bovine respiratory disease in beef cattle. J Anim Sci. 2017 Feb;95(2):626-635. doi: 10.2527/jas.2016.1062. Review. doi: 10.1016/j.prevetmed.2016.07.003. Epub 2016 Aug 31. Review. doi: 10.1016/j.cvfa.2014.11.009. Review. doi: 10.1016/j.tvjl.2013.07.032. Epub 2013 Aug 6. Review. doi: 10.1111/jvp.12080. Epub 2013 Sep 30. Review. doi: 10.1111/jvp.12010. Epub 2012 Oct 22. Review. Epub 2007 Aug 18. Review. Review. Review.
合成参考文献
参考文献:10.1111/j.1365-2885.2011.01322.x 摘要:Wang X, Tao YF, Huang LL, Chen DM, Yin SZ, Ihsan A, Zhou W, Su SJ, Liu ZL, Pan YH, Yuan ZH. Pharmacokinetics of tulathromycin and its metabolite in swine administered with an intravenous bolus injection and a single gavage. J Vet Pharmacol Ther. 2012 Jun;35(3):282–9. doi: 10.1111/j.1365-2885.2011.01322.x. 参考文献:10.1111/j.1365-2885.2011.01300.x 摘要:Clothier KA, Leavens T, Griffith RW, Wetzlich SE, Baynes RE, Riviere JE, Tell LA. Tulathromycin assay validation and tissue residues after single and multiple subcutaneous injections in domestic goats (Capra aegagrus hircus). J Vet Pharmacol Ther. 2012 Apr;35(2):113–20. doi: 10.1111/j.1365-2885.2011.01300.x.